
A 1.6-million-birth analysis finds that adoption of a 2016 trial's antibiotic protocol climbed sharply in US hospitals, with a drop in infection rates.
Instead of keeping transplant patients on long-term immunosuppressants, one hospital tries short-term therapy and is pleased with the results






